Abnormal Sensitivity to Glucose of Human Islets Cultured in a High Glucose Medium: Partial Reversibility after an Additional Culture in a Normal Glucose Medium

1991 ◽  
Vol 72 (1) ◽  
pp. 202-208 ◽  
Author(s):  
ALBERTO M. DAVALLI ◽  
CAMILLO RICORDI ◽  
CARLO SOCCI ◽  
SIMONA BRAGHI ◽  
FEDERICO BERTUZZI ◽  
...  
Hypertension ◽  
2013 ◽  
Vol 62 (suppl_1) ◽  
Author(s):  
Ryousuke Satou ◽  
Andrea Zsombok ◽  
Kayoko Miyata ◽  
Akemi Katsurada ◽  
Andrei V Derbenev

Clinical and basic studies have revealed that the renin-angiotensin system (RAS) plays crucial roles in the development of kidney injury during progression of type 1 diabetes mellitus (T1DM) whereas the activity of systemic RAS is suppressed in T1DM. Thus, intrarenal RAS is increasingly being recognized as an important factor in the development of diabetic nephropathy. We recently demonstrated expression of TRPA1, an oxidative stress-sensitive calcium channel, in renal proximal tubular cells (PTC) and TRPA1 mediates angiotensinogen (AGT) augmentation in the cells. However, regulation and function of the intrarenal TRPA1 in T1DM have not been elucidated. Therefore, this study was performed to evaluate intrarenal TRPA1 expression and its contribution to AGT augmentation under high glucose condition. Streptozotocin (STZ, 200 mg/kg) was intraperitoneally injected to male C57BL/6 mice. Intrarenal TRPA1 expression, kidney AGT, urinary AGT, urinary 8-isoprostane, a maker of oxidative stress, and blood glucose levels were determined one week after STZ injection. Furthermore, contribution of TRPA1 to AGT regulation was tested by using mouse PTC which was cultured with normal (1.0 g/L) or high (4.5 g/L) glucose media. Under these conditions, PTC was treated with 100 μM hydrogen peroxide. Blood glucose and urinary 8-isoprostane levels were higher in the STZ-treated mice compared with control mice. TRPA1 mRNA levels were augmented in the kidney of STZ-treated mice (2.26 ± 0.2, ratio to control mice) accompanied by increases in kidney AGT and urinary AGT levels. TPRA1 upregulation was also observed in PTC which was cultured with the high glucose medium (1.55 ± 0.11, ratio to the normal glucose). Hydrogen peroxide stimulated AGT expression in PTC. The AGT elevation was enhanced in the cultured cells with the high glucose (1.52 ± 0.13-fold in the normal glucose medium vs. 1.97 ± 0.29-fold in the high glucose medium). Treatment with a TRPA1 antagonist attenuated the enhanced AGT augmentation in PTC. These results demonstrate that intrarenal TRPA1 mediates enhanced AGT upregulation under high glucose condition and suggest that intrarenal TRPA1 is implicated in intrarenal RAS activation leading to the development of T1DM-associated diabetic nephropathy.


2019 ◽  
Vol 244 (16) ◽  
pp. 1493-1503 ◽  
Author(s):  
Ya-Nan Wang ◽  
Tingting Jia ◽  
Jiajia Zhang ◽  
Jing Lan ◽  
Dongjiao Zhang ◽  
...  

Type 2 diabetes mellitus (T2DM) is considered to compromise implant osseointegration. Protein tyrosine phosphatase non-receptor type 2 (PTPN2) regulates glucose metabolism, systemic inflammation, and bone regeneration. This study aimed to investigate the role of PTPN2 in implant osseointegration in T2DM and explore the potential mechanisms. Streptozotocin-induced diabetic rats received implant surgery, with or without local overexpression of PTPN2 for three months, and implant osseointegration was examined by histological evaluation, micro-CT analysis, pull-out test, and scanning electron microscope. Rat bone marrow stem cells (RBMSCs) were isolated and exposed to high glucose, and osteogenic differentiation was evaluated by alizarin red staining, ALP assay, and Western blot analysis. Overexpression of PTPN2 could improve impaired implant osseointegration in T2DM rats and promote osteogenic differentiation of RBMSCs in high glucose. In addition, p-ERK level in RBMSCs was increased in high glucose and decreased after PTPN2 overexpression. These results suggest that PTPN2 promotes implant osseointegration in T2DM rats and enhances osteogenesis of RBMSCs in high glucose medium via inducing the dephosphorylation of ERK. PTPN2 may be a novel target for the therapy of impaired implant osseointegration in T2DM patients. Impact statement Using both in vivo and in vitro approaches, we made important findings that PTPN2 promoted implant osseointegration in T2DM rats and enhanced osteogenesis of RBMSCs in high glucose medium. The positive effects of PTPN2 on osteogenesis are related to the dephosphorylation of ERK and the inhibition of MAPK/ERK pathway. PTPN2 may be a novel target for the therapy of impaired implant osseointegration in T2DM patients.


2005 ◽  
Vol 127 (5) ◽  
pp. 758-766 ◽  
Author(s):  
Bram G. Sengers ◽  
Hannah K. Heywood ◽  
David A. Lee ◽  
Cees W. J. Oomens ◽  
Dan L. Bader

A combined experimental-numerical approach was adopted to characterize glucose and oxygen uptake and lactate production by bovine articular chondrocytes in a model system. For a wide range of cell concentrations, cells in agarose were supplemented with either low or high glucose medium. During an initial culture phase of 48h, oxygen was monitored noninvasively using a biosensor system. Glucose and lactate were determined by medium sampling. In order to quantify glucose and oxygen uptake, a finite element approach was adopted to describe diffusion and uptake in the experimental model. Numerical predictions of lactate, based on simple relations for cell metabolism, were found to agree well for low glucose, but not for high glucose medium. Oxygen did not play a role in either case. Given the close association between chondrocyte energy metabolism and matrix synthesis, a quantifiable prediction of utilization can present a valuable contribution in the optimization of tissue engineering conditions.


2008 ◽  
Vol 14 (4) ◽  
pp. 293-297 ◽  
Author(s):  
Ling Qu ◽  
Xiao-chun Liang ◽  
Hong Zhang ◽  
Qun-li Wu ◽  
Lian-qing Sun ◽  
...  

2016 ◽  
Vol 63 (10) ◽  
pp. 474-477
Author(s):  
Hiroshi Shinmoto ◽  
Yoshihito Yamaguchi ◽  
Manami Ito ◽  
Rena Hoshizaki ◽  
Yasunori Naganawa

2021 ◽  
Author(s):  
Tianchi Chen ◽  
Xiangtao Zheng ◽  
Yangyan He ◽  
Chenyang Qiu ◽  
Xiaohui Wang ◽  
...  

Abstract Background Circular RNAs have been demonstrated to play an important role in the development of vascular diseases. However, little is known about the role of circ-021774, also named circ-DAPK1, in vascular cell pyroptosis. Methods Circ-DAPK1 was selected from circular RNA sequencing data of HUVECs treated with high glucose medium and normal medium. RT-qPCR was used to determine the expression of circ-DAPK1 in vivo and in vitro. Dual luciferase reporter assay, fluorescence in situ hybridization (FISH) and RNA immunoprecipitation (RIP) were performed to prove the interaction of circ-DAPK1, miRNA-4454 and thioredoxin-interactingprotein (TXNIP). Adeno-associated virus (AAV) was injected intravenously to establish mouse models. PI staining, western-blot and transmission electron microscopy (TEM) analyses were performed to identify the role of circ-DAPK1 in promoting pyroptosis. Results We found that circ-DAPK1 was highly expressed in high glucose medium cultured HUVECs and db/db mice. In vitro and in vivo experiments demonstrated that circ-DAPK1 knockdown decreased the number of PI+ cells, the expression of ASC, NLRP3, GSDMD-N, cleaved caspase-1, IL-18 and IL-1β. In a mechanistic study, the circ-DAPK1/miRNA-4454/TXNIP signaling axis was demonstrated to promote vascular cell pyroptosis in diabetes. Conclusions Circ-DAPK1 functions as a promoter of vascular cell pyroptosis in diabetes via the circ-DAPK1/miRNA-4454/TXNIP signaling axis.


2012 ◽  
Vol 19 (8) ◽  
pp. 596-602 ◽  
Author(s):  
Xian-pei Heng ◽  
Ke-ji Chen ◽  
Zhen-feng Hong ◽  
Wei-dong He ◽  
Ke-dan Chu ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document